Table 2.
Patient survival and treatment information.
| Patient ID | Diagnosis | Time to Last F/U (Years) | Status at Last F/U | Neo Adjuvant Treatment | Adjuvant Treatment |
|---|---|---|---|---|---|
| PIN 062 | ICC | 3.7 | Alive | None | Gem |
| PIN 065 | PDAC | 1.0 | Deceased | None | Adj radiation, no adj chemo |
| PIN 080 | PDAC | 0.8 | Alive | None | Gem |
| PIN 082 | IPMN | 3.6 | Alive | None | No adj chemo |
| PIN 089 | PDAC | 1.6 | Alive | None | No information |
| PIN 091 | PDAC | 3.1 | Deceased | None | Gem/Oxaliplatin + radiation |
| PIN 099 | PDAC | 1.6 | Deceased | None | Gem |
| PIN 102 | Cholangio | 1.7 | Deceased | None | Adjuvant treatment—regime unknown |
| PIN 112 | PDAC | 2.6 | Alive | None | Gem |
| PIN 113 | PDAC | 0.4 | Deceased | None | Gem |
| PIN 115 | PDAC | 0.0 | Alive | None | - |
| PIN 116 | PDAC | 1.1 | Deceased | None | Gem/Abraxane |
| PIN 120 | PDAC | 1.1 | Alive | None | Gem |
| PIN 127 | PDAC | 2.1 | Deceased | None | Capecitabine |
| PIN 132 | RCC | 2.4 | Alive | None | - |
| PIN 135 | NET | 1.6 | Alive | None | - |
| PIN 137 | PDAC | 2.4 | Alive | None | Gem/Abraxane* |
| PIN 138 | PDAC | 1.7 | Alive | None | Adjuvant treatment + radiation |
| PIN 139 | PDAC | 1.4 | Deceased | FOLFIRINOX + Radiation | Adjuvant treatment—regime unknown |
| PIN 140 | PDAC | 0.4 | Deceased | None | Adjuvant treatment—regime unknown |
| PIN 141 | PDAC | 1.1 | Deceased | None | No information |
| PIN 145 | PDAC | 1.6 | Alive | FOLFIRINOX + Radiation | Adjuvant chemo +radiotherapy |
| PIN 148 | PDAC | 1.8 | Alive | None | No information |
| PIN 160 | PDAC | 1.4 | Deceased | None | Gem |
| PIN 161 | PDAC | - | - | ||
| PIN 165 | PDAC | - | Deceased | FOLFIRINOX +Short Course Radiation | No adj chemo |
| PIN 175 | IPMN | - | Alive | None | Carbo/Etoposide |
| PIN 190 | PDAC | - | Deceased | None | Gem/Abraxane * |
| PIN 191 | PDAC | - | Alive | Gem/Oxaliplatin + Long Course Radiation | No information |
| PIN 194 | PDAC | - | Deceased | Gem/Abraxane + Long Course Radiation | No information |
| PIN 199 | PDAC | - | Alive | Neo-adjuvant—regime unknown | |
| PIN 205 | PDAC | - | - | - | |
| PIN 210 | NET | - | - | - | |
| PIN 211 | PDAC | - | - | - | |
| PIN 212 | MCN | - | - | - | |
| PIN 213 | PDAC | - | - | - | |
| PIN 214 | NET | - | - | - | |
| PIN 218 | NET | - | - | - | |
| PIN 222 | PDAC | - | - | - | |
| PIN 226 | PDAC | - | - | - | |
| PIN 228 | PDAC | - | - | - | |
| PIN 233 | PDAC | - | - | - | |
| PIN 238 | NET | - | - | - | |
| PIN 239 | GIST | - | - | - | |
| PIN 266 | Cholangio | - | - | - | |
| PIN 268 | PDAC | - | - | - | |
| PIN 277 | PDAC | - | - | - | |
| PIN 291 | PDAC | - | - | - |
F/U = Follow-Up; Gem = Gemcitabine; * = (APACT study); “-“ information not available